SciClone Pharmaceuticals

SciClone is a US-based, China-focused specialty pharmaceutical company with a substantial revenue-generating and profitable commercial business and a broad, marketed product portfolio of differentiated therapies for oncology, infectious diseases and cardiovascular, urological, respiratory, and central nervous system disorders.

Type
Public
HQ
Foster City, US
Founded
1989
Employees
590 (est)
SciClone Pharmaceuticals was founded in 1989 and is headquartered in Foster City, US

SciClone Pharmaceuticals Locations

Foster City, US

SciClone Pharmaceuticals Metrics

SciClone Pharmaceuticals Summary

Market capitalization

$531 M

Closing share price

$10.4
SciClone Pharmaceuticals's current market capitalization is $531 M.

SciClone Pharmaceuticals Financials

SciClone Pharmaceuticals's revenue is $157 M in FY, 2015 which is 16.67% increase from the previous period.
FY, 2013FY, 2014FY, 2015

Revenue

$127 M$135 M$157 M

Operating income

$10.4 M$26 M$29.9 M

Net Income

$11 M$25.2 M$29.5 M

Operating cash flow

$1.58 M$425 K$15.2 M

    SciClone Pharmaceuticals Market Value History

    SciClone Pharmaceuticals News

    SciClone Pharmaceuticals Company Life

    You may also be interested in